Clinical trial
A Study Comparing Three Strategies to Switch Patients With Schizophrenia or…
NCT00378183 · Janssen, LP, Industry · Completed
Key facts
| NCT number | NCT00378183 |
|---|---|
| Title | A Study Comparing Three Strategies to Switch Patients With Schizophrenia or Schizoaffective Disorder to Risperidone After Unsuccessful Treatment With Olanzapine. |
| Official title | A Randomized Open-Label, Rater Blinded Assessment of Optimal Treatment Change Strategy to Risperidone for Patients Intolerant of Olanzapine |
| Lead sponsor | Janssen, LP, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizoaffective Disorder, Schizophrenia |
| Intervention type | Drug |
| Interventions | risperidone |
| Enrollment | 120 |
| Start date | Feb 1, 2001 |
| Completion | May 1, 2002 |
| First posted | Sep 19, 2006 |
| Last update posted | Apr 27, 2010 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: